Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Brunner

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Breast (Edinburgh, Scotland)|January 7, 2026
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trialChristian F Singer, Franz Koenig, Stephanie Kacerovsky-Strobl, et al.
International Journal of Molecular Sciences|March 28, 2024
Surface Topography, Microbial Adhesion, and Immune Responses in Silicone Mammary Implant-Associated Capsular FibrosisInes Schoberleitner, Leoni Baier, Michaela Lackner, et al.
Psychoneuroendocrinology|December 18, 2009
Decrease of CD4(+)FOXP3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressorEva Freier, Cora Stefanie Weber, Ulrike Nowottne, et al.
Wiener Klinische Wochenschrift|September 23, 2022
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 updateGabriel Rinnerthaler, Christian Singer, Edgar Petru, et al.
Breast (Edinburgh, Scotland)|March 4, 2022
A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohortAparna Gunda, Chetana Basavaraj, Chandra Prakash Serkad V, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2024
Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective StudyChristine Brunner, Marjan Arvandi, Christian Marth, et al.
NEJM Evidence|February 6, 2024
Long-Term Outcomes of Adjuvant Denosumab in Breast CancerMichael Gnant, Sophie Frantal, Georg Pfeiler, et al.
Nature Cancer|January 17, 2025
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trialGabriel Rinnerthaler, Daniel Egle, Rupert Bartsch, et al.
The New England Journal of Medicine|July 28, 2021
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast CancerMichael Gnant, Florian Fitzal, Gabriel Rinnerthaler, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Breast (Edinburgh, Scotland)|January 7, 2026
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trialChristian F Singer, Franz Koenig, Stephanie Kacerovsky-Strobl, et al.
International Journal of Molecular Sciences|March 28, 2024
Surface Topography, Microbial Adhesion, and Immune Responses in Silicone Mammary Implant-Associated Capsular FibrosisInes Schoberleitner, Leoni Baier, Michaela Lackner, et al.
Psychoneuroendocrinology|December 18, 2009
Decrease of CD4(+)FOXP3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressorEva Freier, Cora Stefanie Weber, Ulrike Nowottne, et al.
Wiener Klinische Wochenschrift|September 23, 2022
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 updateGabriel Rinnerthaler, Christian Singer, Edgar Petru, et al.
Breast (Edinburgh, Scotland)|March 4, 2022
A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohortAparna Gunda, Chetana Basavaraj, Chandra Prakash Serkad V, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2024
Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective StudyChristine Brunner, Marjan Arvandi, Christian Marth, et al.
NEJM Evidence|February 6, 2024
Long-Term Outcomes of Adjuvant Denosumab in Breast CancerMichael Gnant, Sophie Frantal, Georg Pfeiler, et al.
Nature Cancer|January 17, 2025
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trialGabriel Rinnerthaler, Daniel Egle, Rupert Bartsch, et al.
The New England Journal of Medicine|July 28, 2021
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast CancerMichael Gnant, Florian Fitzal, Gabriel Rinnerthaler, et al.
Pageof 3